JP2008519767A5 - - Google Patents

Download PDF

Info

Publication number
JP2008519767A5
JP2008519767A5 JP2007540194A JP2007540194A JP2008519767A5 JP 2008519767 A5 JP2008519767 A5 JP 2008519767A5 JP 2007540194 A JP2007540194 A JP 2007540194A JP 2007540194 A JP2007540194 A JP 2007540194A JP 2008519767 A5 JP2008519767 A5 JP 2008519767A5
Authority
JP
Japan
Prior art keywords
formulation
chemotherapeutic
herbal
paeonia
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007540194A
Other languages
English (en)
Japanese (ja)
Other versions
JP5057987B2 (ja
JP2008519767A (ja
Filing date
Publication date
Priority claimed from US11/100,433 external-priority patent/US7534455B2/en
Application filed filed Critical
Publication of JP2008519767A publication Critical patent/JP2008519767A/ja
Publication of JP2008519767A5 publication Critical patent/JP2008519767A5/ja
Application granted granted Critical
Publication of JP5057987B2 publication Critical patent/JP5057987B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2007540194A 2004-11-09 2005-11-09 薬草組成物phy906及びその化学療法における使用 Expired - Lifetime JP5057987B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US62594304P 2004-11-09 2004-11-09
US60/625,943 2004-11-09
US11/100,433 2005-04-07
US11/100,433 US7534455B2 (en) 2000-03-09 2005-04-07 Herbal composition PHY906 and its use in chemotherapy
PCT/US2005/040605 WO2006053049A2 (en) 2004-11-09 2005-11-09 Herbal composition phy906 and its use in chemotherapy

Publications (3)

Publication Number Publication Date
JP2008519767A JP2008519767A (ja) 2008-06-12
JP2008519767A5 true JP2008519767A5 (enExample) 2010-07-22
JP5057987B2 JP5057987B2 (ja) 2012-10-24

Family

ID=36337179

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007540194A Expired - Lifetime JP5057987B2 (ja) 2004-11-09 2005-11-09 薬草組成物phy906及びその化学療法における使用

Country Status (8)

Country Link
US (1) US7534455B2 (enExample)
EP (1) EP1812028A4 (enExample)
JP (1) JP5057987B2 (enExample)
CN (2) CN104161832A (enExample)
AU (1) AU2005304493B2 (enExample)
CA (1) CA2583761C (enExample)
TW (1) TW200630105A (enExample)
WO (1) WO2006053049A2 (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8871279B2 (en) 2000-03-09 2014-10-28 Yale University Use of the combination of PHY906 and a tyrosine kinase inhibitor as a cancer treatment regimen
US8394365B2 (en) * 2003-09-17 2013-03-12 Nektar Therapeutics Multi-arm polymer prodrugs
CN101730535A (zh) 2007-02-15 2010-06-09 耶鲁大学 草药组合物phy906及其在化疗中的用途
TWI361075B (en) * 2007-03-16 2012-04-01 Brion Res Inst Of Taiwan Pharmaceutical composition for inhibiting the syndrome of snore
CN101918017B (zh) * 2007-10-25 2013-07-31 植物药学公司 Phy906用于治疗炎性肠病和/或肠易激综合征的用途
US20130136811A1 (en) * 2010-05-26 2013-05-30 President And Fellows Of Harvard College Compositions and Methods for Pain Reduction
US8541382B2 (en) 2010-11-13 2013-09-24 Sirbal Ltd. Cardiac glycoside analogs in combination with emodin for cancer therapy
US8734859B1 (en) 2010-11-13 2014-05-27 Sirbal Ltd. Molecular combinations for cancer or other disease treatment
US9095606B1 (en) 2010-11-13 2015-08-04 Sirbal Ltd. Molecular and herbal combinations for treating psoriasis
US9066974B1 (en) 2010-11-13 2015-06-30 Sirbal Ltd. Molecular and herbal combinations for treating psoriasis
US20170049687A1 (en) 2015-07-29 2017-02-23 Sirbal Ltd. Herbal Combinations For Treating Scalp Conditions
WO2015082950A1 (en) 2013-12-02 2015-06-11 Sirbal Ltd. Herbal combinations for treatment of a skin condition
CA3024301A1 (en) * 2016-05-23 2017-11-30 Yale University Improved therapeutic index of anti-immune checkpoint inhibitors using combination therapy comprising a phy906 extract, a scutellaria baicalensis georgi (s) extract or a compound from such extracts
SG11201901540UA (en) * 2016-06-22 2019-04-29 Univ Yale Mechanism based quality control for botanical medicine
US10086026B2 (en) 2016-06-27 2018-10-02 Uwais M. Syed Combined herbal and pharmaceutical composition and method
CN107970299A (zh) * 2017-11-16 2018-05-01 饶本强 一种清热解毒抗肿瘤复方制剂
KR102166949B1 (ko) * 2018-02-28 2020-10-16 중앙대학교 산학협력단 악액질 및 근손실 예방, 개선 또는 치료용 조성물
CN110105149B (zh) * 2019-04-23 2022-02-01 来宾市农业科学院 一种蚕沙防治甘蔗螟虫的方法
CN109991341B (zh) * 2019-05-17 2022-04-01 无限极(中国)有限公司 一种制首乌的质量检测方法
JP2023504202A (ja) * 2019-12-09 2023-02-01 イエール ユニバーシティ がんの再発を予防するための組成物および方法
TW202200183A (zh) * 2020-03-30 2022-01-01 耶魯大學 治療炎性和纖維化疾病和病症的方法
US12011284B2 (en) * 2020-05-19 2024-06-18 Peachy Corp. Systems and methods for preventing and treating wrinkles
TW202337484A (zh) * 2022-03-01 2023-10-01 耶魯大學 用於調節t細胞之活化t細胞核因子(nfat)活性的組成物及方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5936621A (ja) * 1982-08-25 1984-02-28 Tsumura Juntendo Inc 脂肪分解促進作用阻害剤
US5595756A (en) * 1993-12-22 1997-01-21 Inex Pharmaceuticals Corporation Liposomal compositions for enhanced retention of bioactive agents
US5665393A (en) * 1996-09-03 1997-09-09 International Medical Research, Inc. Herbal composition for treating prostate carcinoma
US6048847A (en) * 1997-09-30 2000-04-11 Dabur Research Foundation Use of betulinic acid and its derivatives for inhibiting cancer growth and a method of monitoring this
US6630176B2 (en) * 2000-03-07 2003-10-07 Mount Sinai School Of Medicine Of New York University Herbal remedies for treating allergies and asthma
TWI324069B (en) * 2000-03-09 2010-05-01 Univ Yale Herbal composition phy906 and its use in chemotherapy
WO2002007743A2 (de) * 2000-07-26 2002-01-31 Vitaplant Ag Piper methysticum pflanzenextrakt

Similar Documents

Publication Publication Date Title
JP2004500390A5 (enExample)
CA2633594C (en) Means and methods for the treatment of tumorous diseases
FI3782612T3 (fi) Sytidiinianalogien oraalisia formulaatioita ja menetelmiä niiden käyttämiseksi
AU2005304493B2 (en) Herbal composition PHY906 and its use in chemotherapy
JP2024516795A5 (enExample)
CN103417561A (zh) 芍药苷类化合物在制备抗肿瘤药物中的用途
JP2009515977A5 (enExample)
US8871279B2 (en) Use of the combination of PHY906 and a tyrosine kinase inhibitor as a cancer treatment regimen
JP2015507020A5 (enExample)
JP2010528091A5 (enExample)
CN109985237A (zh) 一种治疗结直肠癌的药物组合物及其应用
JP2010525042A5 (enExample)
JP2023102786A5 (enExample)
JP2008536853A5 (enExample)
JP2024016209A5 (enExample)
Bokemeyer et al. A phase II trial of paclitaxel and weekly 24 h infusion of 5-fluorouracil/folinic acid in patients with advanced gastric cancer
RU2008138534A (ru) Фармацевтическая комбинация для лечения и/или хемосенсебилизации опухолей, устойчивых к противораковым средствам
JP2002326936A5 (enExample)
JP2006503095A5 (enExample)
FI4070800T3 (fi) Kladribiinikuuri multippeliskleroosin hoitoa varten
JP2022512158A5 (enExample)
JP2021517886A5 (enExample)
CN108743601A (zh) 一种抗溃疡性结肠炎的黄芩苷-黄芩素组合物及其制剂
JP2007507482A5 (enExample)
KR20210130768A (ko) 경구 투여된 디옥솔란 뉴클레오타이드와 항-pd1 또는 항-pdl1 단일클론 항체를 함께 사용하여 간암을 치료하는 방법